Email Updates

You are here

Funding Opportunity: RFA-AI-17-028 Next Generation Multipurpose Prevention Technologies (NGM) (R61/R33 - Clinical Trials Optional)

top

NIH/NIAID
Tuesday, September 12, 2017
General

NIAD and NIMH will be accepting applications to support the development of new and innovative multipurpose prevention technologies (MPTs) with the dual purpose of contraception and HIV prevention. Letters of Intent due 19 February 2018.